Cargando…

Atrial high-rate episodes and stroke prevention

While the benefit of oral anticoagulants (OACs) for stroke prevention in patients with atrial fibrillation (AF) is well established, it is not known whether oral anticoagulation is indicated in patients with atrial high-rate episodes (AHRE) recorded on a cardiac implantable electronic device, someti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camm, A. John, Simantirakis, Emmanuel, Goette, Andreas, Lip, Gregory Y.H., Vardas, Panos, Calvert, Melanie, Chlouverakis, Gregory, Diener, Hans-Christoph, Kirchhof, Paulus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400077/ https://www.ncbi.nlm.nih.gov/pubmed/28172715 http://dx.doi.org/10.1093/europace/euw279

Ejemplares similares

Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial
por: Kirchhof, Paulus, et al.
Publicado: (2017)

Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence
por: Bertaglia, Emanuele, et al.
Publicado: (2019)

An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality
por: Aliot, Etienne, et al.
Publicado: (2010)

A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial
por: Kotecha, Dipak, et al.
Publicado: (2017)

Stroke Prevention in Atrial Fibrillation: Concepts and Controversies
por: Ahmad, Yousif, et al.
Publicado: (2012)

Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
por: Khan, Ahsan A., et al.
Publicado: (2019)

Stroke and Bleeding Risk in Atrial Fibrillation
por: Senoo, Keitaro, et al.
Publicado: (2014)

IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial
por: Shantsila, Eduard, et al.
Publicado: (2016)

Stroke Prevention in Atrial Fibrillation: Where are We Now?
por: Ahmad, Yousif, et al.
Publicado: (2012)

The influence of atrial high-rate episodes on stroke and cardiovascular death: an update
por: Toennis, Tobias, et al.
Publicado: (2023)

Cost-effectiveness of early rhythm control vs. usual care in atrial fibrillation care: an analysis based on data from the EAST-AFNET 4 trial
por: Gottschalk, Sophie, et al.
Publicado: (2023)

Emerging Tools for Stroke Prevention in Atrial Fibrillation
por: Voukalis, Christos, et al.
Publicado: (2016)

Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS‐AF Trial
por: Shantsila, Eduard, et al.
Publicado: (2020)

Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
por: Lip, Gregory Y H, et al.
Publicado: (2023)

What do we do about atrial high rate episodes?
por: Boriani, Giuseppe, et al.
Publicado: (2020)

Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Clinical review: Clinical management of atrial fibrillation – rate control versus rhythm control
por: Lim, Hoong Sern, et al.
Publicado: (2004)

XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation
por: Camm, A John, et al.
Publicado: (2014)

Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients
por: Li, Yan-Guang, et al.
Publicado: (2018)

Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation
por: Imberti, Jacopo Francesco, et al.
Publicado: (2022)

Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial( )
por: Eckardt, Lars, et al.
Publicado: (2022)

Improving the diagnosis of heart failure in patients with atrial fibrillation
por: Bunting, Karina V, et al.
Publicado: (2021)

Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices
por: Miyazawa, Kazuo, et al.
Publicado: (2021)

Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices
por: Pastori, Daniele, et al.
Publicado: (2018)

Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial
por: Willems, Stephan, et al.
Publicado: (2021)

Management of atrial fibrillation
por: Kakar, Puneet, et al.
Publicado: (2007)

Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014)

Identifying At‐Risk Patients for Sustained Atrial High‐Rate Episodes Using the C(2)HEST Score: The West Birmingham Atrial Fibrillation Project
por: Li, Yan‐Guang, et al.
Publicado: (2021)

Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes
por: Miyazawa, Kazuo, et al.
Publicado: (2019)

XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
por: Camm, A. John, et al.
Publicado: (2016)

Disparities in atrial fibrillation: a call for holistic care
por: Kotalczyk, Agnieszka, et al.
Publicado: (2021)

European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers
por: Kotecha, Dipak, et al.
Publicado: (2018)

Edoxaban in venous thromboembolism and stroke prevention: an appraisal
por: Proietti, Marco, et al.
Publicado: (2016)

Mechanisms, Risk Factors, and Management of Acquired Long QT Syndrome: A Comprehensive Review
por: Kallergis, Eleftherios M., et al.
Publicado: (2012)

Atrial fibrillation, a contemporary sign of multimorbidity and irregular social inequity
por: Sagris, Dimitrios, et al.
Publicado: (2022)

The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2021)

Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches?
por: Lip, Gregory Y. H., et al.
Publicado: (2014)

Role of Monocytes in Heart Failure and Atrial Fibrillation
por: Shahid, Farhan, et al.
Publicado: (2018)

Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) survey
por: Reiffel, James A, et al.
Publicado: (2023)

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis
por: Wang, Kang-Ling, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cl513dvegct14edtjjfev3rdto